Cicada: New COVID Variant with 70+ Mutations Triggers Cautious Global Watch
Cicada: New COVID Variant with 70+ Mutations Triggers Cautious Global Watch
Health officials monitor Cicada, a highly mutated BA.3.2 COVID variant detected in the US, prompting vigilance as immunity and vaccines face evolutionary change.
New York — A newly identified COVID-19 variant nicknamed Cicada, scientifically BA.3.2, has drawn attention for a heavy mutation load, with roughly 70 to 75 mutations that diverge markedly from recent strains. It remains to be seen whether it will become dominant, but its mutation profile suggests it could potentially slip past immune defenses more easily than some predecessors.
It was first detected through airport screening in the United States in 2025 and has since appeared in patients across multiple states and in wastewater samples spanning at least half the country. While it currently accounts for a fraction of reported cases, wastewater surveillance suggests it could be far more widespread than testing data alone indicate.
Early research indicates Cicada does not necessarily cause more severe illness than current strains, and there has been no spike in deaths linked to this variant. However, experts caution that immunity from past infection or vaccination may be less protective against Cicada, underscoring the virus's ongoing evolution. Vaccines remain useful and should continue to be part of the defense, even as they grapple with this new variant.
Public health officials emphasize that the key message is vigilance: monitor its evolution, maintain protective measures where appropriate, and rely on wastewater data and testing to guide decisions. In the U.S., COVID-19 still exacts a heavy toll, with about 100,000 deaths annually, hitting older adults and the immunocompromised hardest. The takeaway remains clear: stay informed and follow guidance without panic.
